Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-020155
Filing Date
2019-10-11
Accepted
2019-10-10 18:19:16
Documents
3
Period of Report
2019-10-10

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF FOREIGN ISSUER f6k101019_therapixbio.htm 6-K 10410
2 PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON OCTOBER 10, 2019, TITLED "T f6k101019ex99-1_therapixbio.htm EX-99.1 5981
3 GRAPHIC image_001.jpg GRAPHIC 11678
  Complete submission text file 0001213900-19-020155.txt   33669
Mailing Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047
Business Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 191146806
SIC: 2834 Pharmaceutical Preparations